RECOMBINANT-HUMAN-ERYTHROPOIETIN IN ANEMIC PATIENTS ON MAINTENANCE HEMODIALYSIS - COMPARISON BETWEEN INTRAVENOUS AND SUBCUTANEOUS ADMINISTRATION

被引：17

|

作者：

ZEHNDER, C

BLUMBERG, A

机构：

来源：

NEPHRON | 1991年 / 57卷 / 04期

关键词：

D O I：

10.1159/000186357

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：485 / 486

页数：2

相关论文

共 50 条

[1] HUMAN RECOMBINANT ERYTHROPOIETIN (RHUEPO) IN ANEMIC PATIENTS ON MAINTENANCE HEMODIALYSIS (HD) - COMPARISON BETWEEN INTRAVENOUS (IV) AND SUBCUTANEOUS (SC) ADMINISTRATION
ZEHNDER, C
BLUMBERG, A
KIDNEY INTERNATIONAL, 1990, 38 (02) : 372 - 372
[2] INTRAVENOUS VERSUS SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN PATIENTS ON HEMODIALYSIS AND CAPD
EIDEMAK, I
FRIEDBERG, MO
LADEFOGED, SD
LOKKEGAARD, H
PEDERSEN, E
SKIELBOE, M
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1992, 7 (06) : 526 - 529
[3] SUBCUTANEOUS VERSUS INTRAVENOUS RECOMBINANT-HUMAN-ERYTHROPOIETIN ADMINISTRATION IN HEMODIALYSIS-PATIENTS
BORAN, M
DALVA, I
YAZICIOGLU, A
CETIN, S
NEPHRON, 1993, 63 (01) : 113 - 114
[4] RECOMBINANT-HUMAN-ERYTHROPOIETIN IN ANEMIC PATIENTS ON HEMODIALYSIS
BOMMER, J
MULLERBUHL, E
RITZ, E
EIFERT, J
LANCET, 1987, 1 (8529): : 392 - 392
[5] COMPARISON OF THE EFFICACY AND TOLERANCE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN BETWEEN INTRAVENOUS AND SUBCUTANEOUS ROUTES IN CHRONIC-HEMODIALYSIS PATIENTS
RUEDIN, P
STOERMAN, C
PECHEREBERTSCHI, A
LESKI, M
NEPHROLOGIE, 1992, 13 (02): : 87 - 92
[6] COMPARISON OF SUBCUTANEOUS AND INTRAVENOUS RECOMBINANT-HUMAN-ERYTHROPOIETIN FOR ANEMIA IN HEMODIALYSIS-PATIENTS WITH SIGNIFICANT COMORBID DISEASE
MUIRHEAD, N
CHURCHILL, DN
GOLDSTEIN, M
NADLER, SP
POSEN, G
WONG, C
SLAUGHTER, D
LAPLANTE, P
AMERICAN JOURNAL OF NEPHROLOGY, 1992, 12 (05) : 303 - 310
[7] ONCE WEEKLY SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) IN HEMODIALYSIS-PATIENTS
LAGO, M
PEREZGARCIA, R
DEVINUESA, MSG
VILLAVERDE, M
ANAYA, F
VALDERRABANO, F
KIDNEY INTERNATIONAL, 1994, 46 (02) : 579 - 579
[8] KINETICS AND DOSAGE-EFFICACY RELATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN AFTER INTRAVENOUS AND SUBCUTANEOUS ADMINISTRATION IN HEMODIALYSIS AND CAPD PATIENTS
STOCKENHUBER, F
LOIBL, U
JAHN, C
MANKER, W
MEISL, TF
BALCKE, P
NIEREN-UND HOCHDRUCKKRANKHEITEN, 1990, 19 (11) : 497 - 499
[9] RECOMBINANT-HUMAN-ERYTHROPOIETIN TREATMENT IN PATIENTS ON MAINTENANCE HOME HEMODIALYSIS
PASCUAL, J
LIANO, F
MATESANZ, R
TERUEL, JL
ORTUNO, J
NACHRICHTEN FUR DOKUMENTATION, 1991, 42 (05): : 343 - 343
[10] A comparison of subcutaneous (SC) and intravenous (IV) administration of recombinant human erythropoietin (rHuEPO) in hemodialysis (HD) patients
Kaufman, J
Reda, D
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A1012 - A1012

← 1 2 3 4 5 →